The effect of depression on motor function and disease severity of Parkinson's disease

Clinical Neurology and Neurosurgery

Volumn 108, Issue 5, 2006, Pages 465-469

  Papapetropoulos, Spiridon ^a,b   Ellul, John ^a   Argyriou, Andreas A ^a   Chroni, Elisabeth ^a   Lekka, Nicoletta P ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Clinical severity; Depression; Parkinson's disease; UPDRS

Indexed keywords

AMANTADINE; AMITRIPTYLINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CITALOPRAM; DOPAMINE RECEPTOR STIMULATING AGENT; ENTACAPONE; FLUOXETINE; FLUVOXAMINE MALEATE; LEVODOPA; MAPROTILINE; NORTRIPTYLINE; PAROXETINE; SELEGILINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

AGED; ARTICLE; BRADYKINESIA; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; HUMAN; MAJOR DEPRESSION; MOTOR PERFORMANCE; PARKINSON DISEASE; RIGIDITY; SCORING SYSTEM;

CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISABILITY EVALUATION; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; MOVEMENT DISORDERS; PARKINSON DISEASE; PHENOTYPE; PROSPECTIVE STUDIES; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; TREMOR;

EID: 33646565967     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2005.08.002     Document Type: Article

References (53)

1. Cummings J.L. Depression and Parkinson's disease: a review. Am J Psychiatry 149 4 (1992) 443-454
2. Starkstein S.E., Mayberg H.S., Leiguarda R., Preziosi T.J., and Robinson R.G. A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 55 5 (1992) 377-382
3. Mayeux R. Depression in the patient with Parkinson's disease. J Clin Psychiatry 51 Suppl 20-23 (1990) Discussion, 24-5
4. Shiba M., Bower J.H., Maraganore D.M., McDonnell S.K., Peterson B.J., Ahlskog J.E., et al. Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control study. Mov Disord 15 4 (2000) 669-677
5. Leentjens A.F., Van den Akker M., Metsemakers J.F., Lousberg R., and Verhey F.R. Higher incidence of depression preceding the onset of Parkinson's disease: a register study. Mov Disord 18 4 (2003) 414-418
6. Taylor A.E., Saint-Cyr J.A., Lang A.E., and Kenny F.T. Parkinson's disease and depression. A critical re-evaluation. Brain 109 Pt 2 (1986) 279-292
7. Gotham A.M., Brown R.G., and Marsden C.D. Depression in Parkinson's disease: a quantitative and qualitative analysis. J Neurol Neurosurg Psychiatry 49 4 (1986) 381-389
8. Sandyk R. Locus coeruleus-pineal melatonin interactions and the pathogenesis of the "on-off" phenomenon associated with mood changes and sensory symptoms in Parkinson's disease. Int J Neurosci 49 12 (1989) 95-101
9. Kostic V.S., Filipovic S.R., Lecic D., Momcilovic D., Sokic D., and Sternic N. Effect of age at onset on frequency of depression in Parkinson's disease. J Neurol Neurosurg Psychiatry 57 10 (1994) 1265-1267
10. Gupta A., and Bhatia S. Psychological functioning in patients with Parkinson's disease 6 3 (2000) 185-190
11. Brown R.G., MacCarthy B., Gotham A.M., Der G.J., and Marsden C.D. Depression and disability in Parkinson's disease: a follow-up of 132 cases. Psychol Med 18 1 (1988) 49-55
12. Tandberg E., Larsen J.P., Aarsland D., Laake K., and Cummings J.L. Risk factors for depression in Parkinson disease. Arch Neurol 54 5 (1997) 625-630
13. Weintraub D., Moberg P.J., Duda J.E., Katz I.R., and Stern M.B. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease. J Am Geriatr Soc 52 5 (2004) 784-788
14. Starkstein S.E., Preziosi T.J., Bolduc P.L., and Robinson R.G. Depression in Parkinson's disease. J Nerv Ment Dis 178 1 (1990) 27-31
15. Mayeux R., Stern Y., Rosen J., and Leventhal J. Depression, intellectual impairment, and Parkinson disease. Neurology 31 6 (1981) 645-650
16. Hughes A.J., Daniel S.E., Kilford L., and Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55 3 (1992) 181-184 [see comments]
17. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, fourth ed. (DSM-IV) (1994), American Psychiatric Association
18. ® Axis I disorders (SCID-I). Clinician Version. Arlington, VA: American Psychiatric Publishing, Inc.; 2002.
19. Fahn S., and Elton RL. Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. Recent developments in Parkinson's disease (1987), Macmillan Healthcare Information p. 153-63
20. Hoehn M.M., and Yahr M.D. Parkinsonism: onset, progression and mortality. Neurology 17 5 (1967) 427-442
21. Schwab R.S., and England AC. Projection technique for evaluating surgery in Parkinson's disease. In: Gillingham F.D., and IMl (Eds). Proceedings of the third symposium of Parkinson's disease. Livingstone, Edinburgh (1969) 152-157
22. Sheikh J.I., and Yesavage J.A. Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. In: Brink TL. (Ed). Clinical gerontology: a guide to assessment and intervention (1986), The Haworth Press, New York 165-173
23. Cummings J.L. Depression and Parkinson's disease: a review. Am J Psychiatry 149 4 (1992) 443-454
24. Menza M.A., and Mark M.H. Parkinson's disease and depression: the relationship to disability and personality. J Neuropsychiatry Clin Neurosci 6 2 (1994) 165-169
25. Oertel W.H., Hoglinger G.U., Caraceni T., Girotti F., Eichhorn T., Spottke A.E., et al. Depression in Parkinson's disease. An update. Adv Neurol 86 (2001) 373-383
26. Poewe W., and Luginger E. Depression in Parkinson's disease: impediments to recognition and treatment options. Neurology 52 7 Suppl 3 (1999) S2-S6
27. Starkstein S.E., Petracca G., Chemerinski E., and Merello M. Prevalence and correlates of parkinsonism in patients with primary depression. Neurology 57 3 (2001) 553-555
28. Menza M., Marin H., Kaufman K., Mark M., and Lauritano M. Citalopram treatment of depression in Parkinson's disease: the impact on anxiety, disability, and cognition. J Neuropsychiatry Clin Neurosci 16 3 (2004) 315-319
29. Mayeux R., Williams J.B., Stern Y., and Cote L. Depression and Parkinson's disease. Adv Neurol 40 (1984) 241-250
30. Kostic V.S., Djuricic B.M., Covickovic-Sternic N., Bumbasirevic L., Nikolic M., and Mrsulja B.B. Depression and Parkinson's disease: possible role of serotonergic mechanisms. J Neurol 234 2 (1987) 94-96
31. Nuti A., Ceravolo R., Piccinni A., Dell'Agnello G., Bellini G., Gambaccini G., et al. Psychiatric comorbidity in a population of Parkinson's disease patients. Eur J Neurol 11 5 (2004) 315-320
32. Edwards E., Kitt C., Oliver E., Finkelstein J., Wagster M., and McDonald W.M. Depression and Parkinson's disease: a new look at an old problem. Depress Anxiety 16 1 (2002) 39-48
33. Burn D.J. Beyond the iron mask: towards better recognition and treatment of depression associated with Parkinson's disease. Mov Disord 17 3 (2002) 445-454
34. Torack R.M., and Morris J.C. The association of ventral tegmental area histopathology with adult dementia. Arch Neurol 45 5 (1988) 497-501
35. Fahn S., Libsch L.R., and Cutler R.W. Monoamines in the human neostriatum: topographic distribution in normals and in Parkinson's disease and their role in akinesia, rigidity, chorea, and tremor. J Neurol Sci 14 4 (1971) 427-455
36. Jellinger K.A. Morphological substrates of mental dysfunction in Lewy body disease: an update. J Neural Transm Suppl 59 (2000) 185-212
37. Karen A., Szabados K., Reiczigel J., Beckers J.F., and Szenci O. Accuracy of transrectal ultrasonography for determination of pregnancy in sheep: effect of fasting and handling of the animals. Theriogenology 61 7-8 (2004) 1291-1298
38. Ballard C., McKeith I., Burn D., Harrison R., O'Brien J., Lowery K., et al. The UPDRS scale as a means of identifying extrapyramidal signs in patients suffering from dementia with Lewy bodies. Acta Neurol Scand 96 6 (1997) 366-371
39. Papapetropoulos S., Ellul J., Polychronopoulos P., and Chroni E. A registry-based, case-control investigation of Parkinson's disease with and without cognitive impairment. Eur J Neurol 11 (2004) 347-351
40. Andersen J., Aabro E., Gulmann N., Hjelmsted A., and Pedersen H.E. Anti-depressive treatment in Parkinson's disease. A controlled trial of the effect of nortriptyline in patients with Parkinson's disease treated with L-DOPA. Acta Neurol Scand 62 4 (1980) 210-219
41. Laitinen L. Desipramine in treatment of Parkinson's disease. A placebo-controlled study. Acta Neurol Scand 45 1 (1969) 109-113
42. Klaassen T., Verhey F.R., Sneijders G.H., Rozendaal N., de Vet H.C., and van Praag H.M. Treatment of depression in Parkinson's disease: a meta-analysis. J Neuropsychiatry Clin Neurosci 7 3 (1995) 281-286
43. Brooks D.J., and Doder M. Depression in Parkinson's disease. Curr Opin Neurol 14 4 (2001) 465-470
44. Leentjens A.F.G., Verhey F.R.J., and van Praag H.M. Selective serotonin reuptake inhibitors in the treatment of depression in Parkinson's disease: a review of available evidence concerning efficacy, side effects and interactions. In: Wolters E.C.S.P., and Berendse H.W. (Eds). Mental dysfunction in Parkinson's disease (1999), Academic Pharmaceutical Productions, Utrecht 272-284
45. Dell'Agnello G., Ceravolo R., Nuti A., Bellini G., Piccinni A., D'Avino C., et al. SSRIs do not worsen Parkinson's disease: evidence from an open-label, prospective study. Clin Neuropharmacol 24 4 (2001) 221-227
46. Mayberg H.S., and Solomon D.H. Depression in Parkinson's disease: a biochemical and organic viewpoint. Adv Neurol 65 (1995) 49-60
47. Rektorova I., Rektor I., Bares M., Dostal V., Ehler E., Fanfrdlova Z., et al. Pramipexole and pergolide in the treatment of depression in Parkinson's disease: a national multicentre prospective randomized study. Eur J Neurol 10 4 (2003) 399-406
48. Goldberg J.F., Burdick K.E., and Endick C.J. Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression. Am J Psychiatry 161 3 (2004) 564-566
49. Lattanzi L., Dell'Osso L., Cassano P., Pini S., Rucci P., Houck P.R., et al. Pramipexole in treatment-resistant depression: a 16-week naturalistic study. Bipolar Disord 4 5 (2002) 307-314
50. Giladi N., Treves T.A., Paleacu D., Shabtai H., Orlov Y., Kandinov B., et al. Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease. J Neural Transm 107 1 (2000) 59-71
51. Hughes T.A., Ross H.F., Musa S., Bhattacherjee S., Nathan R.N., and Mindham R.H. A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease. Neurology 54 8 (2000) 1596-1602
52. Okun M.S., and Watts R.L. Depression associated with Parkinson's disease: clinical features and treatment. Neurology 58 4 Suppl 1 (2002) 63-70
53. Brown R.G., MacCarthy B., Gotham A.M., Der G.J., and Marsden C.D. Depression and disability in Parkinson's disease: a follow-up of 132 cases. Psychol Med 18 1 (1988) 49-55